Vogliviga GM2/0.3 Tablet in PCD pharma franchise in Hyderabad

Vogliviga GM2/0.3 Tablet in pharmaceutical manufacturing company in Mumbai

Vogliviga GM2/0.3 Tablet in diabetic pharma franchise in Pune

Vogliviga GM2/0.3 Tablet in pharma suppliers in Delhi

Vogliviga GM2/0.3 Tablet in pharma export companies in Kolkata
Vogliviga GM2/0.3 Tablet in pharma franchise opportunities in Bengaluru

Vogliviga GM2-0.3 Tablet

Composition : Glimepride I.P. 2mg + Voglibose I.P. 0.3mg + Metformin HCL I.P. 500mg (S.R.) Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹190/-

Please Contact For Best Price

Vogliviga GM2/0.3 Tablet combines Glimepiride 2mg, Voglibose 0.3mg, and Metformin 500mg (Sustained Release) in a bi-layered tablet designed for effective management of type 2 diabetes mellitus. Glimepiride stimulates insulin secretion to lower blood sugar levels, Voglibose delays carbohydrate absorption to reduce post-meal glucose spikes, and sustained-release Metformin improves insulin sensitivity while reducing glucose production in the liver. This multi-action formulation helps maintain balanced blood glucose levels throughout the day.

Read More

About the Product

Vogliviga GM2/0.3 Tablet combines Glimepiride 2mg, Voglibose 0.3mg, and Metformin 500mg (Sustained Release) in a bi-layered tablet designed for effective management of type 2 diabetes mellitus. Glimepiride stimulates insulin secretion to lower blood sugar levels, Voglibose delays carbohydrate absorption to reduce post-meal glucose spikes, and sustained-release Metformin improves insulin sensitivity while reducing glucose production in the liver. This multi-action formulation helps maintain balanced blood glucose levels throughout the day.

Common side effects may include gastrointestinal discomfort such as nausea, abdominal pain, bloating, and diarrhea. Hypoglycemia can occur, particularly if meals are missed or dosing is incorrect. Long-term use of Metformin may lead to vitamin B12 deficiency in some patients.

This tablet is indicated for the treatment of type 2 diabetes mellitus, especially in patients who require better control of both fasting and postprandial blood sugar levels.

Not suitable for patients with type 1 diabetes, diabetic ketoacidosis, or severe liver and kidney impairment. Alcohol consumption should be avoided. Regular monitoring of blood sugar is essential, and the medication should be taken as directed by a healthcare professional.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch